Literature DB >> 17854885

Maternal and neonatal tetanus.

Martha H Roper1, Jos H Vandelaer, François L Gasse.   

Abstract

Maternal and neonatal tetanus are important causes of maternal and neonatal mortality, claiming about 180 000 lives worldwide every year, almost exclusively in developing countries. Although easily prevented by maternal immunisation with tetanus toxoid vaccine, and aseptic obstetric and postnatal umbilical-cord care practices, maternal and neonatal tetanus persist as public-health problems in 48 countries, mainly in Asia and Africa. Survival of tetanus patients has improved substantially for those treated in hospitals with modern intensive-care facilities; however, such facilities are often unavailable where the tetanus burden is highest. The Maternal and Neonatal Tetanus Elimination Initiative assists countries in which maternal and neonatal tetanus has not been eliminated to provide immunisation with tetanus toxoid to women of childbearing age. The ultimate goal of this initiative is the worldwide elimination of maternal and neonatal tetanus. Since tetanus spores cannot be removed from the environment, sustaining elimination will require improvements to presently inadequate immunisation and health-service infrastructures, and universal access to those services. The renewed worldwide commitment to the reduction of maternal and child mortality, if translated into effective action, could help to provide the systemic changes needed for long-term elimination of maternal and neonatal tetanus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854885     DOI: 10.1016/S0140-6736(07)61261-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  77 in total

Review 1.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

Review 2.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus.

Authors:  Hannah Blencowe; Joy Lawn; Jos Vandelaer; Martha Roper; Simon Cousens
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

Review 3.  Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance.

Authors:  Michelle H Moniz; Richard H Beigi
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

4.  [Insufficient tetanus vaccination protection in psoriasis and systemic immunosuppression : Results of a retrospective investigation of 101 patients].

Authors:  W Sondermann; L Leister; N Rompoti; J Dissemond; J Klode; A Körber
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique.

Authors:  Heather M Scobie; Minal Patel; Diana Martin; Harran Mkocha; Sammy M Njenga; Maurice R Odiere; Sonia Pelletreau; Jeffrey W Priest; Ricardo Thompson; Kimberly Y Won; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2016-12-05       Impact factor: 2.345

6.  Three cases of neonatal tetanus in Papua New Guinea lead to development of national action plan for maternal and neonatal tetanus elimination.

Authors:  Siddharta Sankar Datta; Roland Barnabas; Adeline Sitther; Laura Guarenti; Steven Toikilik; Grace Kariwiga; Gerard Pai Sui
Journal:  Western Pac Surveill Response J       Date:  2013-06-26

Review 7.  Immunization During Pregnancy: Impact on the Infant.

Authors:  Kirsten P Perrett; Terry M Nolan
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

8.  Elimination of maternal and neonatal tetanus: a 21st-century challenge.

Authors:  Sharon Owusu-Darko; Khady Diouf; Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2012

9.  Generalized tetanus in a 4-year old boy presenting with dysphagia and trismus: a case report.

Authors:  Petrus Rudolf de Jong; Thea de Heer-Groen; Cornelis Hendrik Schröder; Nicolaas Johannes Georgius Jansen
Journal:  Cases J       Date:  2009-04-29

10.  Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.

Authors:  Syed Imteyaz Alam; Sunita Bansod; Lokendra Singh
Journal:  BMC Microbiol       Date:  2008-11-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.